Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NBMI Announces Issuance of Patent for Hearing Amplification Technology

Abstract:
Charles Seeney, President and CEO of NBMI, announced today that the company has been awarded a US Patent for the company's hearing amplification technology.

NBMI Announces Issuance of Patent for Hearing Amplification Technology

Edmond, OK | Posted on October 27th, 2010

The award is the company's third issued patent overall and the second on hearing remediation. The novel technology is based on magnetically responsive nanoparticles, implanted in middle ear tissue, vibrating in response to an oscillating magnetic coil. The concept of a commercial hearing device would be similar to current electromagnetic hearing aids. The company also has eight additional patent applications working their way through the US Patent Office.

Seeney states that "We are obviously excited about this new patent award, because it further strengthens our growing Intellectual Property base, not only for this health care application, but also for validation of magnetic vectoring as an emerging "nanotool." Because NBMI is not an audiology company, NBMI will continue the development and commercialization of an implantable hearing technology through partnerships and licenses.

The Patent technology, which was filed in 2005, was developed through collaborations with scientists at the University of Oklahoma and the Massachusetts Eye and Ear Infirmary, Affiliate of Harvard Medical School. Seeney notes that the studies at the Massachusetts Eye and Ear Infirmary were also supported in part by an OCAST Grant.

NBMI's business focus is the development and commercialization of healthcare applications based on the use of magnetically responsive nanoparticles, which cause or drive a desired physiological event, under the influence of an external focused magnetic field. The company's second platform is the targeted delivery of therapeutics, with primary focus on the tumor-specific delivery of chemotherapeutics.

Safe Harbor Statement:
Certain statement included in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of products and services, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. The company's expectations regarding future revenues are dependent upon the ability to develop and supply products and services that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions are generally considered forward-looking statements. These statements reflect current expectations.

####

About NanoBioMagnetics
NanoBioMagnetics (NBMI) is a nanobiomaterials company pioneering an emerging area of nanomedicine referred to as organ-assisting-device (OAD) technologies, in which magnetically responsive nanoparticles (MNP), under the influence of external shaped magnetic fields, are magnetically vectored to cause or drive a desired physiological event. OAD healthcare applications are being developed under two proprietary platforms (patents pending).

For more information, please click here

Contacts:
Charles E Seeney
Ph: 405.844.5118

Copyright © NanoBioMagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Oxford Instruments announces Dr Kate Ross as winner of the 2018 Lee Osheroff Richardson Science Prize for North and South America February 20th, 2018

Computers aid discovery of new, inexpensive material to make LEDs with high color quality February 20th, 2018

Unconventional superconductor may be used to create quantum computers of the future: They have probably succeeded in creating a topological superconductor February 19th, 2018

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Nanomedicine

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers February 15th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

Announcements

Oxford Instruments announces Dr Kate Ross as winner of the 2018 Lee Osheroff Richardson Science Prize for North and South America February 20th, 2018

Computers aid discovery of new, inexpensive material to make LEDs with high color quality February 20th, 2018

Unconventional superconductor may be used to create quantum computers of the future: They have probably succeeded in creating a topological superconductor February 19th, 2018

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Patents/IP/Tech Transfer/Licensing

NTU scientists create customizable, fabric-like power source for wearable electronics January 30th, 2018

IBM Breaks Records to Top U.S. Patent List for 25th Consecutive Year: IBM Inventors Receive Record 9,043 Patents in 2017 in Areas such as Artificial Intelligence, Cloud, Blockchain, Cybersecurity and Quantum Computing January 11th, 2018

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

Chinese market opens up for Carbodeon nanodiamonds: Carbodeon granted Chinese Patent for Nanodiamond-containing Thermoplastic Thermal Compounds December 4th, 2017

Nanobiotechnology

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers February 15th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project